Additionally, direct comparisons between CIRP and established biomarkers, such as C-reactive protein, IL-6, and TNF-α, should be conducted to assess their predictive value, sensitivity, and specificity for stroke outcomes. The gene discussed is IL6; the disease is stroke disorder.